Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We hereby consent to the use in this Registration Statement on Form 10 of our report dated February 14, 2017, relating to the financial statements of Monopar Therapeutics Inc. as of and for the year ended December 31, 2016 and 2015, which appears in such Registration Statement.

 

/s/ BPM LLP

 

San Francisco, California

November 9, 2017